PF
AZN icon

Phoenix Financial’s AstraZeneca AZN Stock Holding History

Phoenix Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.5M Sell
139,398
-262,802
-65% -$50.7M 0.26% 57
2025
Q4 		$73.9M Sell
402,200
-130
-0% -$22.8K 0.8% 32
2025
Q3 		$61.7M Sell
402,330
-3,469
-0.9% -$525K 0.75% 35
2025
Q2 		$56.7M Sell
405,799
-172,204
-30% -$24.1M 0.75% 34
2025
Q1 		$85M Sell
578,003
-39,107
-6% -$5.66M 1.3% 28
2024
Q4 		$80.9M Buy
617,110
+581,328
+1,625% +$81.4M 1.1% 31
2024
Q3 		$5.59M Sell
35,782
-5,833
-14% -$942K 0.08% 129
2024
Q2 		$6.5M Sell
41,615
-5,291
-11% -$796K 0.1% 115
2024
Q1 		$6.35M Buy
46,906
+758
+2% +$100K 0.09% 117
2023
Q4 		$6.45M Buy
46,148
+19,499
+73% +$2.53M 0.11% 95
2023
Q3 		$3.63M Buy
+26,649
New +$3.64M 0.07% 134
2023
Q2 		– Sell
-732,073
Closed -$102M – 326
2023
Q1 		$102M Buy
732,073
+112,878
+18% +$15.2M 2.27% 14
2022
Q4 		$84M Sell
619,195
-168,934
-21% -$21.2M 1.63% 20
2022
Q3 		$86.6M Buy
788,129
+77,018
+11% +$9.77M 1.91% 14
2022
Q2 		$94M Sell
711,111
-145,950
-17% -$19.2M 1.92% 10
2022
Q1 		$114M Sell
857,061
-154,220
-15% -$18.5M 1.91% 9
2021
Q4 		$118M Buy
1,011,281
+310,956
+44% +$36.6M 1.94% 9
2021
Q3 		$84.1M Buy
700,325
+244,251
+54% +$28.4M 1.46% 17
2021
Q2 		$54.6M Buy
456,074
+132,159
+41% +$14.5M 1.04% 26
2021
Q1 		$32.2M Buy
323,915
+263,915
+440% +$26.5M 0.73% 44
2020
Q4 		$5.99M Buy
+60,000
New +$6.36M 0.16% 125

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Phoenix Financial's AZN Position: Q1 2026 in Review

Phoenix Financial reduced its AstraZeneca (AZN) stake by 65% in Q1 2026, selling an estimated $50.7M and leaving 139,398 shares worth $27.5M. The position accounts for 0.26% of the portfolio, ranked #57.

Phoenix Financial first reported a position in AZN in Q4 2020 and has held it in 21 quarters since. The position peaked at $118M in Q4 2021. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Phoenix Financial held 139,398 shares of AstraZeneca worth $27.5M as of Q1 2026.
  • Phoenix Financial sold 262,802 AstraZeneca shares in Q1 2026, an estimated $50.7M.
  • AstraZeneca made up 0.26% of Phoenix Financial's portfolio in Q1 2026, its #57 holding.
  • Phoenix Financial first reported a position in AstraZeneca in Q4 2020 and has held it in 21 quarters since.
  • Phoenix Financial's AstraZeneca position peaked at $118M in Q4 2021.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Phoenix Financial's 13F filing for Q1 2026, filed 11 May 2026.